Align Technology ALGN
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Align Technology (ALGN) Business Model and Operations Summary
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Key Insights
Align Technology (ALGN) Core Market Data and Business Metrics
Latest Closing Price
$158.08Market Cap
$11.66 BillionPrice-Earnings Ratio
26.98Total Outstanding Shares
73.60 Million SharesTotal Employees
20,945Dividend
No dividendIPO Date
January 26, 2001SIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
NASDAQHeadquarters
410 North Scottsdale Road, Suite 1300, Tempe, AZ, 85288
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow | $-196.37 Million |
| Net Cash Flow From Operating Activities, Continuing | $499.05 Million |
| Net Cash Flow From Financing Activities | $-502.98 Million |
| Net Cash Flow From Investing Activities | $-214.32 Million |
| Net Cash Flow From Operating Activities | $499.05 Million |
| Net Cash Flow, Continuing | $-218.25 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Cost Of Revenue | $1.19 Billion |
| Selling, General, and Administrative Expenses | $1.74 Billion |
| Operating Income/Loss | $635.02 Million |
| Operating Expenses | $2.14 Billion |
| Nonoperating Income/Loss | $-10.64 Million |
| Income Tax Expense/Benefit, Deferred | $21.57 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss Attributable To Parent | $33.87 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Comprehensive Income/Loss | $475.44 Million |
| Other Comprehensive Income/Loss | $475.44 Million |
| Comprehensive Income/Loss Attributable To Parent | $475.44 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Other Current Assets | $2.27 Billion |
| Prepaid Expenses | $72.98 Million |
| Noncurrent Assets | $3.77 Billion |
| Fixed Assets | $1.29 Billion |
| Inventory | $254.12 Million |
| Current Liabilities | $2.06 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||